Open AccessSerum Interleukin-10 But Not Interleukin-6 Is Related to Clinical Outcome in Patients With Resectable Hepatocellular Carcinoma
Author(s) -
GarYang Chau,
Chew-Wun Wu,
WingYiu Lui,
TsanKuo Chang,
Hua-Li Kao,
LiHwa Wu,
KuangLiang King,
CheChuan Loong,
Chen-Yuang Hsia,
ChinWen Chi
Publication year - 2000
Publication title -
annals of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.153
H-Index - 309
eISSN - 1528-1140
pISSN - 0003-4932
DOI - 10.1097/00000658-200004000-00015
Subject(s) - medicine , hepatocellular carcinoma , clinical significance , gastroenterology , univariate analysis , interleukin , cytokine , multivariate analysis , carcinoma , interleukin 10 , disease , interleukin 6 , oncology
To evaluate the clinical significance of preoperative serum levels of interleukin-10 (IL-10) and interleukin-6 (IL-6) in patients with resectable hepatocellular carcinoma (HCC).